Rationale: In the
glioblastoma (GBM) microenvironment, tumor-associated macrophages (TAMs) are prominent components and facilitate
tumor growth. The exact molecular mechanisms underlying TAMs' function in promoting
glioma stem cells (GSCs) maintenance and
tumor growth remain largely unknown. We found a candidate molecule,
transforming growth factor beta-induced (TGFBI), that was specifically expressed by TAMs and extremely low in GBM and GSC cells, and meanwhile closely related to
glioma WHO grades and patient prognosis. The exact mechanism of TGFBI linking TAM functions to GSC-driven
tumor growth was explored. Methods: Western blot, quantitative real-time PCR (qRT-PCR),
enzyme-linked
immunosorbent assay (ELISA), immunofluorescence (IF), immunohistochemistry staining (IHC) and public datasets were used to evaluate TGFBI origin and level in GBM. The response of GSCs to recombinant human TGFBI was assessed in vitro and orthotopic xenografts were established to investigate the function and mechanism in vivo. Results: M2-like TAMs infiltration was elevated in high-grade
gliomas. TGFBI was preferentially secreted by M2-like TAMs and associated with a poor prognosis for patients with GBM. TGFBI promoted the maintenance of GSCs and GBM malignant growth through
integrin αvβ5-Src-Stat3 signaling in vitro and in vivo. Of clinical relevance, TGFBI was enriched in the serum and CSF of GBM patients and significantly decreased after
tumor resection. Conclusion: TAM-derived TGFBI promotes GSC-driven
tumor growth through
integrin αvβ5-Src-Stat3 signaling. High serum or CSF TGFBI may serve as a potential diagnostic and prognostic bio-index for GBMs.